Post by Mediamedic

🎗️🔬 Why Does Immunotherapy Fail in Some Patients? Professor Tao Xu’s Team Identifies a New Resistance Mechanism in Urothelial Carcinoma Immunotherapy has transformed the treatment landscape for advanced urothelial carcinoma, yet a substantial proportion of patients fail to achieve durable benefit. Understanding why resistance occurs remains one of the most important challenges in cancer research. 💡 In a groundbreaking study, Professor Tao Xu’s team sheds new light on the biological mechanisms underlying immunotherapy resistance in urothelial carcinoma, providing valuable insights into how tumors evade immune attack and identifying potential avenues for improving treatment outcomes. 📖 Read more to explore Professor Xu’s team’s discoveries, the scientific basis of immunotherapy resistance, and how these findings may contribute to the development of more effective precision immunotherapy strategies for patients with urothelial carcinoma. #TaoXu #UrothelialCarcinoma #Immunotherapy #CancerResearch #PrecisionMedicine #TranslationalResearch #Oncology